Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Sevita Inducted as Newest Partner in National Military Spouse Employment Program

Sevita

As part of an ongoing commitment to strengthen its diverse and inclusive workforce, Sevita, a leading national provider of community-based health care and support services, has been inducted into the U.S. Department of Defense Military Spouse Employment Program (MSEP). Undersecretary of Defense for Personnel and Readiness Gilbert R. Cisneros, Jr., welcomed the new companies into the partnership during an induction ceremony and annual event in Arlington, Virginia, on October 25. The Military Spouse Employment Program (MSEP) partners with companies across the United States to provide recruitment and employment solutions for military spouses – a population of highly qualified individuals that experiences higher unemployment rates and wage gaps than their civilian counterparts, often due to the demands of military family life and frequent relocation. Employers inducted into the program undergo an intense and robust vetting process by Department of Defense professionals. According to the Department of Defense, there are currently about 1 million military spouses. Over the past decade, the rate of unemployment has been steady at around 21%, as it is a challenge for military spouses to find and maintain employment with frequent permanent change of station moves. MSEP currently partners with more than 600 employers that have hired over 250,000 military spouses since its inception in 2011. The goal of the program is to provide education and career guidance to military spouses worldwide. “Our employees are at the heart of Sevita’s mission-based purpose, and we believe military spouses are a great fit for our organization and the work we do caring for others. Sevita’s culture of respect and inclusion, growth and opportunity, and responsibility to our communities aligns with military values,” said Paul Norman, Vice President of Talent Acquisition at Sevita. “As a national provider of home and community-based health care services, we offer opportunities in 41 states, flexible work schedules, remote work opportunities, professional growth and development, and the opportunity to develop caring and long-lasting relationships with the individuals we serve.” Sevita proudly commits to recruiting, hiring, retaining, and promoting military veterans, active duty members, and military spouses, and there are currently more than 3,400 employees who report having served in the military. The partnership with the MSEP is aligned with the company’s mission to help the individuals we support live a full, more independent life, despite the challenges they face. The MSEP partnership is an opportunity for Sevita to strengthen connections within the military community to help military spouses find and maintain meaningful employment, job satisfaction, and career progression while they face the challenge of frequent relocation. Sevita is a leading provider of community-based specialized health care, inspired by our core values of respect, integrity, inclusion and growth. We provide people with quality services and individualized supports that lead to growth and independence, despite the physical, intellectual, or behavioral challenges they face. We’ve made this our mission for more than 50 years. Today our team members continue to innovate and enhance care for the 50,000+ individuals we serve. sevitahealth.com Contact Details Melissa Patricio media@sevitahealth.com Company Website https://sevitahealth.com/

November 11, 2022 10:00 AM Eastern Standard Time

Image

Adrian Cheng Launches The WEMP Foundation, First Non-Profit Dedicated to Children’s Mental Health

The WEMP Foundation

Non-profit is joined by heavyweight advisors to support underserved children in Hong Kong; innovative family programme has already benefited over 20,000 students and parents to date HONG KONG SAR - Media OutReach - 11 November 2022 - Children are the key to the future of society. Creating a healthy and positive environment in which they grow and reach their full potential is therefore imperative. Yet, during nearly three years of the pandemic, many children from underprivileged families are faced with mental problems of varying degrees. To meet this mental health challenge and to provide professional one-stop services on children's mental health support, Adrian Cheng, Chief Executive Officer of New World Development (0017.HK), has personally founded the non-profit organisation The WEMP Foundation, and invited a star-studded advisory committee from across professionals to share innovative, positive parenting skills with parents and teachers. The move is also in response to the ongoing need to enhance social mental health services and support for children and families in Hong Kong. Since its launch, The WEMP Foundation has benefited over 20,000 students and parents. The WEMP Foundation is founded by New World Development CEO Adrian Cheng to bring all-round improvements to the wellbeing and mental health of children. The WEMP Foundation aims to nurture and improve four key attributes, namely Wellbeing, EQ, Mental Health and Positive Parenting. According to recent research on the mental health of children and teens, nearly 40% of primary and secondary school students in Hong Kong are showing signs of mental illness. Symptoms include a loss of focus, anxiety and insomnia; suicide rate among teenagers is also climbing, with few seeking psychological support. The problem is strikingly worse among students and parents from underprivileged families. The WEMP Foundation aims to nurture and improve four key attributes, namely Wellbeing, EQ, Mental Health and Positive Parenting. Adrian Cheng: Nurturing Wellness and Mental Health of the Next Generation. Adrian Cheng, the Founder of The WEMP Foundation, said, "Children are tomorrow's leaders, and it is only by creating a healthy environment, with a great mental health and wellness support system, can children grow to reach their full potential, and positively lead our future community. I am excited to announce the official launch of The WEMP Foundation, which will help Hong Kong parents and teachers in their responsibilities of educating and nurturing children. I would also like to thank all our advisors for their continuous guidance, and for joining us on this meaningful journey of nurturing wellness and mental health of the next generation." Integrated Power House to Empower Children, Parents and Schools The WEMP Foundation is an all-round collaboration platform that brings together children, parents, schools and community. It actively offers one-stop, innovative parenting education and children's mental health support, and through the collective knowledge and resources of experts from various industries, it aims to protect and safeguard the mental health of underserved children, in order to create a positive and loving environment in which they grow. Introducing Innovative, Positive Parenting Skills and Mental Health Knowledge Many parents in Hong Kong are faced with different degrees of parenting challenges, in particular on how to deal with their children's emotions. These include the pressure felt by primary school students during their studies, as well as primary and secondary school students' addiction to computer games and other rebellious behaviours. If ignored by parents, these problems will often create insecurity among children; while if parents choose to deal with these issues by beating, scolding or forcing them to obey, children will feel anxious and uneasy, often bottling up their negative emotions. When faced with even bigger setbacks, these frustrations can easily snowball into mental health problems. The WEMP Foundation plans to introduce positive parenting skills training to 10 kindergartens, with the goal of sharing positive parenting skills and mental health knowledge to over 10,000 kindergarten parents and children. It is set to be Hong Kong's first education programme that targets early childhood mental health. In addition, the WEMP Foundation is also collaborating with various partners to introduce positive parenting skills and educational activities on emotions to schools across 18 districts, with an aim to benefit 20,000 students and parents. Building a "Happy Home" Through Film Appreciation As a means for parents to learn about positive parenting skills, The WEMP Foundation has collaborated with a number of non-profit organisations to screen the award-winning micro-film "Sounds of Silence". The micro-film tells the story of a 10-year-old boy who is emotionally devastated following the loss of his grandmother. Through a touching story, it brings out the common psychological distress and needs of children, including the need for mothers to listen to their troubles when they feel anxious, when their video game addiction is mistaken for rebellion, or when they blame themselves for their own shortcomings. The WEMP Foundation has also invited renowned educator Charles Yu to share three tips for building a "Happy Home", namely be rational, be optimistic and be far-sighted. According to Yu, rational communication can avoid arguments, while parents should stay optimistic and believe in their children's ability to self-correct and grow through their own mistakes. At the same time, Yu states that parents should be far-sighted, and begin developing their children's merits at an early age, as children's personality and inter-personal skills are often developed early on. Contact Details Corporate Communication Department, New World Development Maggie Yeung +852 3721 2721 maggieyeung@nwd.com.hk

November 11, 2022 08:32 AM Eastern Standard Time

Image

For Over 20 Years, DentalPlans.com Has Helped Customers Get Access To Affordable Dental Healthcare –- Their Plans Can Be Used With Medicare

DentalPlans.com

Though millions struggle with sickness every year in America, many people are more afraid of exorbitant medical costs than they are of the health risks associated with putting off treatment. Uncertainty over healthcare costs or available financial resources deters 35% of people from seeking the treatment they need. More than 63 million people are enrolled in the government’s Medicare program. Through Original Medicare coverage, these people — those older than 65, disabled youth and dialysis patients — get access to affordable healthcare, though regular dental care is not included. This year, the open enrollment period, when users can add, switch or modify their Medicare coverage, is from Oct. 15 to Dec. 7. About 24 million have dental insurance coverage as part of Medicare Advantage, a separate health insurance plan through approved insurance carriers. One company looking to increase people’s options when it comes to accessing affordable dental care is DentalPlans.com, which provides a marketplace of dental saving plans where patients can shop for a plan that best fills the gaps they may have with their Medicare coverage. This could be great news for Medicare patients looking to amplify their dental coverage. Neither Original Medicare nor Medicare Supplement covers routine or regular dental treatments, and while Medicare Advantage does include dental, it works the same way as private insurance. The annual caps are frequently low, meaning patients can be left with large out of pocket expenses, while coinsurance costs can be up to 50% of the original price. Regardless of their coverage type, customers can save when they choose to include a dental savings plan. The Solution Where You Can Plan On Savings DentalPlans.com is an online marketplace where users can find more than 30 dental savings plans accepted by over 140,000 dentists across America. For over 20 years, DentalPlans.com has helped customers get plans that give access to affordable dental care, and these plans can be used in conjunction with Medicare. Operating like a membership club like Costco Wholesale Corp. or Sam’s Club, plan members pay a low annual cost for their dental savings plan, and then receive savings at the dentist all year long. These savings are not subject to annual limits or health restrictions, and surveyed customers using dental saving plans indicated savings of 50% per dental visit, though savings vary based on provider and location. DentalPlans.com prides itself on being the largest marketplace where customers can find membership to a host of plans that feature low-hassle signups and quick plan activation. One example of how those with Medicare can benefit from dental savings plans are dentures. Dentures are not covered under Original Medicare, which is composed of hospital and medical insurance (Parts A and B). While Medicare Advantage plans (Part C) may include dentures, for many it is still worth getting a dental savings plan in conjunction with Medicare. This makes dental savings plans an attractive option for those with both Original Medicare and Medicare Advantage. Dental savings plans often include procedures like dentures and cosmetics, as well as helping lower dental bills after Medicare Advantage coverage has been maxed out. To learn more about DentalPlans.com, visit its website. DentalPlans.com, founded in 1999, is a leading online marketplace for dental savings plans in the U.S., helping more than a million people to affordably access quality healthcare services. Our mission is to empower consumers with the tools, information, and services that they need to live happier, healthier lives. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Matthew Wong matthew.wong@wpromote.com Company Website https://www.dentalplans.com/

November 11, 2022 08:15 AM Eastern Standard Time

Hear the Holidays: Ways to Help People with Hearing Loss Enjoy the Holidays

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/yQwa2WRw59E The holidays are a time to share special moments with loved ones and celebrate those relationships, but if you have hearing loss and are struggling to hear or follow conversations, you may feel disconnected from family and friends this holiday season. Often, feelings of embarrassment or frustration can cause individuals with hearing loss to stop socializing or participating in events or activities that they used to enjoy. According to a HearingLife and Harris Poll survey, 72% of people with hearing loss wish their hearing was better to enjoy holiday and special gatherings*. HearingLife is celebrating the holiday season with the “Hear the Magic. Love Your Ears” holiday campaign accompanied by the second annual “Magic of Giving Back” program aimed to help those with hearing loss gain back the joyful sounds of the holiday season. "We understand the challenges that come with hearing loss, such as difficulty following conversations and feeling embarrassed," said Dr. Leslie Soiles, Chief Audiologist, HearingLife. "At HearingLife, we believe everyone deserves to hear their favorite sounds of the season and we want to help those in need regain their confidence and enjoy connecting with loved ones during the holiday season." For the opportunity to receive free hearing aids through the “Magic of Giving Back,” people can submit either a personal story, or a story on behalf of a loved one, explaining why they are a candidate for the gift of hearing. To learn more and share your story, visit www.HearingLife.com/Magic by November 12th About HearingLife: HearingLife is a national hearing care company and part of the Demant Group, a global leader in hearing healthcare built on a heritage of care, health, and innovation since 1904. HearingLife operates nearly 700 hearing care centers across 42 states. We follow a scientific, results-oriented approach to hearing healthcare that is provided by highly skilled and caring professionals. Our vision is to help more people hear better through life-changing hearing health delivered by the best personalized care. To learn more, visit: https://www.hearinglife.com. *Survey Method: This survey was conducted online within the United States by The Harris Poll on behalf of HearingLife from August 19-23, 2021, among 2,044 adults ages 18+, among whom 253 have hearing loss. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact hearinglife@kaplow.com. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 10, 2022 04:00 PM Eastern Standard Time

Video

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Organicell Regenerative Medicine, Inc.

Learn more about Organicell Regenerative Medicine, Inc.from this latest report. During the peak of the deadly COVID-19 pandemic, one novel therapeutic that seems to have played an important role in helping save lives was Organicell Regenerative Medicine Inc. ’s (OTCMKTS: OCEL) Zofin™. Even though COVID-19 therapies and vaccines have been dominated by big players like BioNTech SE — ADR (NASDAQ: BNTX), Johnson & Johnson (NYSE: JNJ), Moderna Inc. (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE), the U.S. Food and Drug Administration (FDA) approved Zofin™ to be used for patients — some whose conditions were serious and life-threatening. The company hit a significant milestone in October 2020 when the FDA granted expanded access for patients to be treated with their flagship therapeutic, Zofin™. The FDA gave Emergency Investigational New Drug (eIND) approval for treating COVID-19. The investigational product was used for patients with mild to moderate COVID-19 or who were judged to be at high risk of progression to moderate disease. Zofin™, manufactured to retain naturally occurring microRNAs without adding any other substance or diluent, was reportedly among the first reported acellular therapies accessed under the FDA’s approved expanded access program. The FDA approval followed the treatment of six outpatients treated under investigational new drugs (INDs) status with Zofin™. Organicell reported chalking up another win when in May 2021, the Drug Regulatory Authority of Pakistan approved Zofin™ for use with patients on compassionate grounds following the patient’s COVID-19 diagnosis and admittance to an intensive care unit for treatment on a ventilator. These huge stamps of approvals from major regulatory authorities seem to have put the spotlight on Organicell, indicating that it could be doing something extraordinary and is a company to watch. The devastating impact of the COVID-19 pandemic on humanity and the global economy has triggered a sudden wake-up call for an all-hands-on-deck approach to developing vaccines and therapies to shore up humanity’s immunity against present and future viruses. Companies like Organicell could play a key role. For most investors, identifying publicly-traded companies like Organicell with the most promising prospects for converting research and development initiatives into commercial remedies could pay off. What Makes Organicell Different? Based in Nova Southeastern University’s (NSU) Center for Collaborative Research, Organicell is a clinical-stage research company with a mission to be the first company to prove the efficacy of extracellular vesicles (EVs) — also known as exosomes — in clinical trials for several conditions. The fully integrated clinical-stage biotechnology company says it is committed to researching, developing and manufacturing new biologic medicine, focusing on current and potential regenerative therapeutics. Comprised of two arms — clinical research and commercial — Organicell generates revenue by extracting and delivering potent formulas of EVs for topical, skincare applications. The company reports that its proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring exosomes, hyaluronic acid, growth factors, and key proteins without adding or combining any other substance or diluent. Zofin™ Organicell is actively investigating the therapeutic safety and efficacy of Zofin™ in subjects with various stages of COVID-19 infection — mild to moderate, moderate to severe, and post-COVID-19 complications a.k.a Long Haulers. Through the FDA’s single-patient emergency and compassionate use mechanism, Organicell has treated 18 subjects to observe Zofin™ safety while secondarily observing clinical improvements. Zofin™ was administered intravenously to these patients, who were followed for 28 days post-therapy. Under expanded access, Zofin™ has been administered to patients with mild to moderate COVID-19 infections. These studies demonstrate the first use of a human perinatal-derived nanoparticle biologic as a safe and potentially efficacious treatment for acute respiratory distress syndrome induced by COVID-19 infection. Cheaper And Easier Clinical Trials? According to Organicell, Zofin™ is naturally derived and, therefore, only requires 30 patients to complete Phase I/II trials of clinical trials. Phase III trials should require only 250-300 patients, while clinical trials are currently enrolling and anticipated to be completed within 24 months. Clinical trials are a crucial element of the drug development process, but they are often expensive, with costs running into hundreds of millions of dollars. Organicell says its trials are cheaper and faster than those of other companies. The company reports that the cost per trial is approximately $10 million with only 250-350 patients needed, compared to others that cost hundreds of millions of dollars and involve more patients. “When people hear about clinical trials, they immediately get spooked because they think hundreds of millions of dollars and tens of thousands of patients,” Organicell’s President and Acting CEO Matt Sinnreich told Benzinga. “Since we are a biologic, we have a much smaller requirement.” With an entire clinical trial costing about $10 million, Sinnreich believes the company is “well positioned to get Phase I / Phase II enrolled and has a board of directors that can help with additional funding needs.” Apart from Zofin™, Organicell is also working on PPX, Factor X, and XoTin. The company says it is looking at health and beauty partnerships, clinical trials to pursue a Biologics License Application (BLA), and evolving the science to address other specific ailments. Unlike other companies that may be spending on speculative research, Organicell says it is already generating revenue with an ultimate goal to uplist soon. Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and the provision of other related services. The Company's proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring exosomes, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Organicell Investor Relations IR@organicell.com Company Website https://organicell.com/

November 10, 2022 02:17 PM Eastern Standard Time

Dynamic Works Institute to Launch CWDP Recertification Package at NAWDP Youth Symposium

Dynamic Works Institute

Dynamic Works Institute, a leading provider of transformative training for individuals, corporations and community-based organizations, will introduce its new Certified Workforce Development Professional (CWDP) Recertification Package at the National Association of Workforce Development Professionals (NAWDP) 2022 Youth Symposium, booth 211. The show will take place from November 14-16 at The Westin Charlotte (Charlotte, N.C.). Achieving CWDP certification demonstrates that a workforce development professional has completed the required training In order to maintain their CWDP certification, workforce development professionals must complete at least 60 hours of professional development related to one or more of the five competencies identified by NAWDP, which include: Customer Service Methodology, Diversity in Workforce Development, Labor Market Information and Intelligence, Principles of Communication, and Workforce Development Structure, Policies and Programs. The new CWDP Recertification Package from Dynamic Works Institute is specifically designed and delivered by workforce training experts to accommodate the schedules of busy professionals who wish to recertify for their CWDP certification. The Recertification Package includes a selection of live and asynchronous online course options covering all five core competencies identified by NAWDP, which customers can attend as their schedules allow. “We’re excited to introduce our new CWDP Recertification program, as it addresses an unmet need to help busy workforce development professionals receive the training they need for recertification,” said Paul Dunn, CEO of Dynamic Works Institute. “Our live and asynchronous online courses work with our customers’ busy schedules to build on their current skills and help improve job performance. In addition, they are specifically designed to meet the requirements outlined by NAWDP for CWDP recertification.” Dynamic Works Institute’s new Recertification Package can provide the full 60 hours of instruction required for CWDP recertification or supplement any remaining required hours necessary. Customers can choose from a selection of 30, 15 and 10-hour course options, with packages focused on case management, customer empowerment, working with special populations, and more. In addition, all customers are enrolled in 10 hours of free live training to support their success and build a network of peers. After finishing the course, customers receive their completed NAWDP paperwork and application form available for download and submission. To learn more about Dynamic Works Institute’s new CWDP Recertification Package, stop by booth 211 at the NADWP 2022 Youth Symposium, or visit https://dynamicinstitute.com/. About Dynamic Works Institute Dynamic Works Institute offers over 300 virtual, interactive courses, coaching and live webinars to transform the value and success individuals, corporations and community-based organizations derive from their work. The company’s convenient and relevant virtual training services, complemented with extreme customer service, develop the skills and mindsets that make work life more fulfilling. Contact Details Dynamic Works Institute Gena Leisten +1 513-238-4665 gleisten@dwfs.us O’Keeffe PR Dan O’Keeffe +1 513-221-1526 dan@okeeffepr.com Company Website https://dynamicinstitute.com

November 10, 2022 10:03 AM Eastern Standard Time

McQueen Kalligan Insurance Services Joins AmeriLife & AIMCOR Group as First Affiliate Under New Joint Venture

AmeriLife

AIMCOR Consolidated LLC (“ICON”), a joint venture between AIMCOR Group, LLC (“AIMCOR”) and AmeriLife Group, LLC (“AmeriLife”), announced today that it has acquired brokerage general agency McQueen Kalligan Insurance Services, Inc. Per the agreement, terms of the deal were not disclosed. "We’re very excited to officially join ICON and formalize our partnership with AmeriLife, which will help accelerate our goal of providing best-in-class insurance solutions to our brokers and their clients,” said Tim McQueen, president and CEO of McQueen Kalligan. “This new platform offers us a wide selection of product, technology, and back office support, and will allow us to grow the business while maintaining the service excellence our brokers and advisors have become accustomed to." Founded in 1982 with offices in California and Oregon, McQueen Kalligan started as a small Transamerica general agency and has since evolved into a multi-carrier brokerage general agency (BGA), offering its affiliated agents and advisors a diverse portfolio of life, long-term care, disability, and annuities products from top carriers. McQueen Kalligan is a founding member of AIMCOR Group, and now – under ICON and as an affiliate of AmeriLife – joins a best-in-class distribution network that will help it further its growth goals and expand its reach. With the closing of this deal, Tim McQueen also becomes a principal in ICON and will continue to oversee his affiliated office locations alongside his existing leadership team. In a joint statement, Mike Vietri, Chief Distribution Officer of AmeriLife, and John C. Ziambras, president and CEO of AIMCOR Group, said: “The addition of McQueen Kalligan to ICON represents the start of a fresh, new approach to insurance distribution. We’re thrilled to welcome Tim and his team, and equally as excited to get to work together to help power the next era of the firm’s growth.” “We’re honored to announce McQueen Kalligan Insurance Services as ICON’s inaugural affiliate. Tim McQueen and his team truly epitomize our collective mission and fully embrace our long-term strategy and value proposition,” added Marc Verbos, president of ICON. “I’ve had the pleasure of working alongside Tim and his team for the past eight years, and I know the passion and commitment that they have for supporting their agents and advisors to better protect their clients’ financial futures.” ### About McQueen Kalligan McQueen Kalligan Insurance Services, Inc. is a brokerage general agency (BGA) offering several lines of individual insurance protection. The original agency began in Torrance, Calif., in 1982, and now has locations in San Diego, La Palma, and in Bend, Oregon. McQueen Kalligan’s team members are dedicated to top quality service and problem solving for the financial professionals they work with to provide solutions for business owners, families and estates. For more information, visit MKISInc.com. About ICON ICON (“AIMCOR Consolidated LLC”) is a joint venture between AIMCOR Group, LLC and AmeriLife Group, LLC. By combining the power of a premier national marketing organization (“NMO”) with capital resources, innovative technology, a multi-product platform and a robust suite of centralized shared services, ICON offers brokerage general agencies (BGAs) a different way to stay competitive and evolve their business. ICON helps its partners focus on long-term sustainability by helping reduce risk, gain access to capital, and empower their ability to deliver a comprehensive portfolio of products and services, all while supporting their producers so that they can better scale their business, protect their legacy, and enhance their service offerings. Contact Details AmeriLife Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com ICON Mike English +1 866-428-0180 mike.english@aimcorgroup.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com

November 10, 2022 09:00 AM Eastern Standard Time

New Report Reveals the Potential Reach of Direct Primary Care to Employers

Nice Healthcare

A new report published by an independent risk management consulting firm, Milliman, commissioned by Nice Healthcare, shows that the Nice Healthcare’s integrated healthcare model addresses services that are used by 89% of healthcare utilizers in a typical large employer commercial health benefit plan, based on a study of historical data. The data underlying the research included 58 million member months of exposure and more than $28 billion in allowed claims. “Our focus is on how we can bring better access at an affordable price to small businesses,” says Thompson Aderinkomi, CEO of Nice Healthcare. “Our model also provides support to health plans by being the first line of care enabling providers to only see the patients who need them most.” Using a mix of technology, logistics, and expert clinical care, Nice Healthcare brings a fully integrated clinic to the patient, providing in-home and virtual primary care, mental health therapy, physical therapy, and medications. The service is a direct-to-employer benefit and can help health plans avoid high-dollar claims and wasteful care. Aligned with Nice’s mission of accessible services, the study found that the services Nice can address make up the majority of healthcare costs typically incurred at urgent care facilities or via telehealth. With Nice, you can get a visit, labs, x-rays and more right in your home. Nice also offers virtual visits, giving patients quick answers to their healthcare questions without relying on insurance, networks, or scheduling around busy work days. To read the full study visit https://www.milliman.com/en/insight/Benchmarking-cost-and-utilization-of-direct-primary-care-services. Nice Healthcare is making truly integrated comprehensive healthcare accessible, allowing patients to easily get care for their everyday needs. Using a mix of technology, logistics, and expert clinical care, they bring a fully integrated clinic to you, providing in-home and virtual primary care, mental health therapy, and physical therapy. Their clinicians can also offer patients x-rays, 35 labs and blood draws and a formulary with over 550 medications with no out-of-pocket costs. Since launching in Minnesota in 2017, Nice has expanded its integrated care services to 12 states. Contact Details Nice Healthcare pr@nice.healthcare +1 586-461-2103 pr@nice.healthcare Company Website https://www.nice.healthcare/

November 10, 2022 09:00 AM Eastern Standard Time

The NIH Has Given BioRestorative Therapies A Stamp Of Approval

BioRestorative Therapies, Inc.

BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes. BioRestorative’s novel drug BRTX-100, which is approved by the Food and Drug Administration (FDA) to enter Phase 2 clinical trials, targets damaged and degenerating discs. The Company is well into its trial, a 99-patient prospective, randomized, double-blinded, controlled study, the gold standard of its kind. BRTX-100 is an autologous stem cell product that uses the patient’s own stem cells, which are harvested, cultured, combined with their own autologous platelet lysate and then injected directly into the affected disc to initiate the healing and repair process. Previous human investigator-initiated studies using a similar product to BRTX-100 (but arguably less potent) have shown a reduction in pain and increase in function in excess of the stated primary endpoints in BioRestorative’s phase 2 protocol. This fascinating opportunity presents a study that is highly suggestive of the potential outcomes for which they are currently processing. In addition, the treatment is anticipated to be safer, cheaper and more effective with a single treatment. BioRestorative’s other product — ThermoStem — has highly promising results in the treatment of obesity and related diseases. Obesity affects over 40% of Americans, and BioRestorative is developing a novel stem-cell population — brown adipose tissue — that shows signs of regulating metabolic activity and reducing excess fat. BioRestorative Therapies Has Joined The Leagues Of 23andMe, Qualcomm and Naviscan In September 2021, BioRestorative was awarded a Small Business Technology Transfer (STTR) phase I grant for $256,000. The project seeks to evaluate the therapeutic effects on the company’s hypoxic cultured bone marrow derived mesenchymal stem cells (BRTX-100) after encapsulation with a PEG-peptide hydrogel. The work is being done in collaboration with Dr. Lori Setton, Chair of the Department of Biomedical Engineering at Washington University in St. Louis. SBIR is a federal program coordinated by the Small Business Administration that funds research and development. STTR is a Small Business Innovation Research (SBIR) sister program. The programs are one of the largest sources of funding for early-stage companies. Big-name companies like 23andMe Holding Co. (NASDAQ: ME), Qualcomm Inc. (NASDAQ: QCOM) and Naviscan Inc. were awarded SBIR and STTR funding, which helped them become the companies they are today. SBIR and STTR programs are highly competitive programs that foster and encourage small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for product commercialization. Through this highly competitive awards-based program, SBIR and STTR enable small businesses to explore their technological potential and provide the incentive to profit from its commercialization. SBIR and STTR are like gold mines for smaller companies. Borrowing from a bank is often difficult for new, innovative businesses because they lack collateral and revenue to help secure loans. While venture capital often fills the gap, it’s not always available and companies can lose autonomy if a venture capital firm wants to have a heavier hand in decisions. With the SBIR and STTR programs, funding is stable and predictable as it is an award, not a loan. Small businesses retain intellectual property rights. Additionally, the National Institute of Health (NIH), which oversees the programs, provides recognition, validation and visibility to early-stage companies that they might not otherwise have with either a loan from a bank or venture capital. Receiving an SBIR and STTR award can also help attract more funding because of the prestige associated with the programs. SBIR and STTR programs have supported the development of 99 drugs from 1996-2020. Of these drugs, 16% of all treatments made a “significant” advance over available medicines. Companies that receive SBIR and STTR awards are put on the map and can credibly say they were backed by the NIH. With the recent grants BioRestorative Therapies has received, the NIH has given the company a stamp of approval. To learn more about BioRestorative Therapies, visit its website. BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.Today, BioRestorative is actively developing programs that aim to dramatically increase quality of care for both (i) chronic back pain caused by disc degeneration, as well as (ii) metabolic disorders including obesity and diabetes. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Investor Relations ir@biorestorative.com Company Website https://www.biorestorative.com/

November 10, 2022 08:00 AM Eastern Standard Time

1 ... 188 189 190 191 192 ... 300